Gregg Fine

Gregg Fine

GlaxoSmithKline - Needham / United Kingdom
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4370612
-
person_outline Gregg Fine's MOST POPULAR ARTICLES
1-) Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patientsRS Herbst, JC Soria, M Kowanetz, GD Fine, O Hamid, MS Gordon, ...Nature 515 (7528), 563-567, 201446102014
2-) TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cellsS Mariathasan, SJ Turley, D Nickles, A Castiglioni, K Yuen, Y Wang, ...Nature 554 (7693), 544-548, 201836732018
3-) Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm …JE Rosenberg, J Hoffman-Censits, T Powles, MS Van Der Heijden, ...The Lancet 387 (10031), 1909-1920, 201636662016
4-) Early childhood development coming of age: science through the life courseMM Black, SP Walker, LCH Fernald, CT Andersen, AM DiGirolamo, C Lu, ...The Lancet 389 (10064), 77-90, 201730392017
5-) MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancerT Powles, JP Eder, GD Fine, FS Braiteh, Y Loriot, C Cruz, J Bellmunt, ...Nature 515 (7528), 558-562, 201426642014